Teva Pharmaceutical Industries (NYSE:TEVA) Raised to “Buy” at StockNews.com
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Friday. Other equities research analysts have also issued reports about the company. Piper Sandler boosted their price objective on Teva Pharmaceutical Industries from $23.00 to $30.00 and […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Friday. Other equities research analysts have also issued reports about the company. Piper Sandler boosted their price objective on Teva Pharmaceutical Industries from $23.00 to $30.00 and […]